June 26, 2024Published by lixte-biotech on June 26, 2024Categories ArticlesArticle: A combination of protein phosphatase 2A inhibition and checkpoint immunotherapy: a perfect stormBy Mary C. Clark, Rongze Olivia Lu, Winson S. Ho, Matheus Henrique Dias, René Bernards, […]
June 10, 2024Published by lixte-biotech on June 10, 2024Categories ArticlesArticle: The case for therapeutic overactivation of oncogenic signaling as a potential cancer treatment strategy in Cancer CellBy Matheus Henrique Dias, Chrysa Papagianni, Rene Bernards Volume 42, Issue 6, 10 June 2024, […]
April 30, 2024Published by lixte-biotech on April 30, 2024Categories ArticlesArticle: Too much of a good thing in Nature Reviews CancerResearch Highlight | Published: 30 April 2024 Targeted Therapies | By Anna Dart Many […]
February 5, 2024Published by lixte-biotech on February 5, 2024Categories ArticlesArticle: LOS ANGELES BUSINESS JOURNAL: Lixte CEO Takes On a New CoursePasadena-based pharmaceutical company Lixte Biotechnology Holdings Inc.’s new chief executive is also charting a new […]